SCHEMBL807235

SCHEMBL807235

c1ccc2c(CN3CCCCC3)ccnc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.68
LMNA P02545 4/20 0.68
ALDH1A1 P00352 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
NPSR1 Q6W5P4 2/20 0.68
HRH3 Q9Y5N1 8/20 0.57
FAAH O00519 1/20 0.56
TP53 P04637 2/20 0.56
ALOX12 P18054 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
BRD4 O60885 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
LOXL2 Q9Y4K0 1/20 0.51
HTT P42858 2/20 0.50
NPC1 O15118 2/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31010255 1.00 KDM4E (0.68) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL23507365 0.98 KDM4E (0.70) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL27318452 0.87 KDM4E (0.60) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL14980282 0.84 SMN1; SMN2 (0.69) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL31428721 0.84 ALDH1A1 (0.69) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL3707217 0.84 LMNA (0.65) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL28228172 0.82 HRH3 (0.59) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL23775340 0.81 KDM4E (0.66) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL14375211 0.81 ACHE (0.62) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1
SCHEMBL8821312 0.81 KDM4E (0.62) KDM4ELMNAALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036997-A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS SCHERING CORPORATION (US) 2012-03-22 WO disclosed